[Respective roles of hemodynamic or humoral factors and of hypotensive or salidiuretic drugs in the development of essential hypertension].
D000328:Adult; D002752:Chlorthalidone / Q000627:therapeutic use; D004039:Diet, Sodium-Restricted; D004562:Electrocardiography; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000209:etiology / Q000401:mortality / Q000503:physiopathology*; D006974:Hypertension, Malignant / Q000628:therapy; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D011379:Prognosis; D012110:Reserpine / Q000627:therapeutic use; D012964:Sodium / Q000378:metabolism; D013148:Spironolactone / Q000627:therapeutic use; D013562:Sympathectomy
D006852:Hydrochlorothiazide; D013148:Spironolactone; D008750:Methyldopa; D012110:Reserpine; D012964:Sodium; D002752:Chlorthalidone; D006145:Guanethidine
Role respectif des facteurs hémodynamiques ou humoraux et des médications hypotensive ou salidiurétique, dans l'évolution de l'hypertension "essentielle".